| Financial Year |
March 31 2023 |
| Monetary Funds |
945,616,432.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
158,918,432.60 |
| Advances to Suppliers |
149,621,862.09 |
| Other Receivables |
238,596,748.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
343,119,554.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
469,189,594.18 |
| Total Current Assets |
2,305,170,184.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,318,091.81 |
| Investment Properties |
14,854,345,046.83 |
| Fixed Assetes |
2,942,610,506.51 |
| Under-construction Projects |
1,114,374,765.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,589,296,347.22 |
| R&D expenses |
1,674,993.28 |
| Goodwill |
537,387,757.77 |
| Long-Term Deferred and Prepaid Expenses |
1,080,717,269.72 |
| Deferred Income Tax Assets |
84,297,972.13 |
| Other Non-Current Assets |
314,801,603.04 |
| Sub-Total of Non-Current Assets |
24,547,602,142.99 |
| Total Assets |
26,852,772,327.28 |
| Short-Term Loans |
6,252,238,771.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
542,193,046.12 |
| Accounts Payable |
2,524,266,429.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
347,514,371.10 |
| Taxes Payable |
159,873,961.81 |
| Interest Payable |
-- |
| Dividend Payable |
21,138,122.32 |
| Other payables |
3,855,626,963.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
639,286,915.23 |
| Other Current Liabilities |
102,663,981.36 |
| Sub-Total of Current Liabilities |
15,216,158,971.35 |
| Long-term Loans |
3,788,252,080.35 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
520,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
18,561,130.87 |
| Deferred Income Tax Liabilities |
763,537,998.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,645,158,921.78 |
| Total Liabilities |
21,861,317,893.13 |
| Paid-In Capital(Or Share Stock) |
863,903,951.00 |
| Capital Surplus |
3,608,872,877.48 |
| Surplus Reserve |
313,793,537.85 |
| LESS:Treasury Stock |
299,928,121.62 |
| Undistributed Profits |
-2,556,286,945.97 |
| Minority Stockholder's Interest |
348,200,448.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,643,253,985.20 |
| Owner's Equity（Stockholder's Equity） |
4,991,454,434.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,852,772,327.28 |
